サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424113

在宅ヘルスケア市場、シェア、規模、動向、産業分析レポート：コンポーネント別、地域別、セグメント別予測、2024年～2032年

Home Healthcare Market Share, Size, Trends, Industry Analysis Report, By Component (Equipment, Service); By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
在宅ヘルスケア市場、シェア、規模、動向、産業分析レポート：コンポーネント別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の在宅ヘルスケア市場規模は2032年までに6,997億4,000万米ドルに達する見込みです。本レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

在宅ヘルスケアで使用される患者中心の戦略は、患者の転帰の改善、ケア期間の延長、費用対効果、不必要な入院の減少など、数多くのメリットをもたらします。このような利点から、在宅ヘルスケアの採用が増加し、在宅ヘルスケア市場の成長を促進すると予想されます。

世界の在宅ヘルスケア市場は、遠隔地から患者に質の高い医療サービスを提供することを目的とした、ヘルスケアシステムにおける遠隔医療技術の採用増加により拡大しています。遠隔医療分野における研究開発イニシアチブの大幅な増加と相まって、先端技術の広範な利用が市場の拡大を支えています。

病院のベッドやその他の医療サービスのコスト上昇により、快適で信頼でき、効率的で手頃な在宅サービスを求める患者が増加しています。人工呼吸器、ネブライザー、持続的気道陽圧（CPAP）装置など、必要不可欠な製品の需要は一定しています。

新興国市場における在宅ヘルスケアサービスの認知度向上、在宅ヘルスケアにおける先端技術の迅速な導入、アルツハイマー病や認知症などの健康状態に対処する老年人口の増加などの要因により、この市場は大きなビジネスチャンスを提供しています。これは市場プレーヤーにとって大きなチャンスです。

介護付き有料老人ホームや介護施設に入居するよりも、自宅で老後を過ごしたいと考える高齢者が増えています。この動向の主な要因は、長期介護にかかる高額な費用と、自立と自律を維持したいという強い願望です。同時に、核家族（子供がいない、大人全員が働いている家族）が一般的になりつつあります。介護に割ける時間は限られているため、こうした家族は、高齢者や障害のある家族に必要なサポートや支援を、プロの在宅ヘルスケアサービスに頼ることが多いです。

在宅ヘルスケア市場レポートハイライト

在宅ヘルスケア市場では、自宅での治療需要の急増により、サービス分野が最大の売上シェアを占めています。高齢化社会が急速に進展し、慢性疾患と診断されるリスクが高まっています。

北米が最大の市場シェアを占めています。利便性、費用対効果、プライバシー、さまざまな医療サービスに対する償還の利用しやすさ、サービスの拡大、医療機器メーカーによる在宅ヘルスケアサービスや在宅ヘルスケアプロバイダーの設定で使用するための多数の製品やサービスプロバイダーの発売などの利点により、在宅ヘルスケアに対する患者の嗜好が高まっていることが、市場成長の原動力となっています。

在宅ヘルスケア市場はアジア太平洋地域が最も急速に成長しています。同地域では高齢者人口が急速に増加しており、この人口動態の変化と高齢者の慢性疾患有病率の増加が市場成長の原動力となっています。さらに、在宅ヘルスケアサービスの利用しやすさと費用対効果に関する一般市民の意識の高まり、ヘルスケアインフラの進歩、地域事業体による多様な在宅ヘルスケアソリューションの導入などが、同地域の市場に好影響を与えると予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の在宅ヘルスケア市場に関する洞察

  • 在宅ヘルスケア市場- 業界スナップショット
  • 在宅ヘルスケア市場力学
    • 促進要因と機会
      • 在宅ヘルスケア機器の可用性が高まることで市場の成長が促進される
      • 在宅ヘルスケアにおける急速な技術進歩が市場の成長を促進する
    • 抑制要因と課題
      • 病院のヘルスケアと比較して健康基準が不足していると、市場の成長が妨げられる
  • PESTLE分析
  • バリューチェーン分析
  • 在宅ヘルスケア業界の動向
  • COVID-19感染症の影響分析

第5章 世界の在宅ヘルスケア市場、コンポーネント別

  • 主な調査結果
  • イントロダクション
  • 装置
  • サービス

第6章 世界の在宅ヘルスケア市場、地域別

  • 主な調査結果
  • イントロダクション
    • 在宅ヘルスケア市場評価、地域別、2019-2032年
  • 在宅ヘルスケア市場-北米
    • 北米：在宅ヘルスケア市場、コンポーネント別、2019～2032年
    • 在宅ヘルスケア市場-米国
    • 在宅ヘルスケア市場- カナダ
  • 在宅ヘルスケア市場- 欧州
    • 欧州：在宅ヘルスケア市場、コンポーネント別、2019～2032年
    • 在宅ヘルスケア市場- 英国
    • 在宅ヘルスケア市場- フランス
    • 在宅ヘルスケア市場- ドイツ
    • 在宅ヘルスケア市場- イタリア
    • 在宅ヘルスケア市場- スペイン
    • 在宅ヘルスケア市場- オランダ
    • 在宅ヘルスケア市場- オーストリア
  • 在宅ヘルスケア市場- アジア太平洋
    • アジア太平洋：在宅ヘルスケア市場、コンポーネント別、2019～2032年
    • 在宅ヘルスケア市場- 中国
    • 在宅ヘルスケア市場- インド
    • 在宅ヘルスケア市場- マレーシア
    • 在宅ヘルスケア市場- 日本
    • 在宅ヘルスケア市場- インドネシア
    • 在宅ヘルスケア市場- 韓国
  • 在宅ヘルスケア市場-中東およびアフリカ
    • 中東およびアフリカ：在宅ヘルスケア市場、コンポーネント別、2019～2032年
    • 在宅ヘルスケア市場- サウジアラビア
    • 在宅ヘルスケア市場- アラブ首長国連邦
    • 在宅ヘルスケア市場- イスラエル
    • 在宅ヘルスケア市場- 南アフリカ
  • 在宅ヘルスケア市場-ラテンアメリカ
    • ラテンアメリカ：在宅ヘルスケア市場、コンポーネント別、2019～2032年
    • 在宅ヘルスケア市場- メキシコ
    • 在宅ヘルスケア市場- ブラジル
    • 在宅ヘルスケア市場- アルゼンチン

第7章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第8章 企業プロファイル

  • A&D Company
  • Abbott Laboratories
  • Amedisys
  • Almost Family
  • BAYADA Home Health Care
  • Bayer AG
  • Fresenius
  • GE Healthcare
  • Kindred Healthcare
  • Kinnser Software
  • Linde Corporation
  • LHC Group
  • McKesson Corporation
  • Omron Healthcare
  • Philips Healthcare
  • Portea Medical
  • Roche Holding AG
図表

List of Tables

  • Table 1 Global Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 2 Home Healthcare Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 3 North America: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 4 U.S.: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 5 Canada: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 6 Canada: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 7 Europe: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 8 Spain: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 9 Netherlands: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 10 Austria: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 11 Germany: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 12 Italy: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 13 France: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 14 Asia Pacific: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 15 China: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 16 Japan: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 17 India: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 18 Indonesia: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 19 South Korea: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 20 Malaysia: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 21 Latin America: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 22 Brazil: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 23 Mexico: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 24 Argentina: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 25 Middle East & Africa: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 26 South Africa: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 27 Israel: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 28 Saudi Arabia: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • Table 29 UAE: Home Healthcare Market, by Component, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Home Healthcare Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Component
  • Figure 7 Global Home Healthcare Market, by Component, 2022 & 2032 (USD Billion)
  • Figure 8 Home Healthcare Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 9 Strategic Analysis - Home Healthcare Market
目次
Product Code: PM1600

The global home healthcare market size is expected to reach USD 699.74 billion by 2032, according to a new study by Polaris Market Research. The report "Home Healthcare Market Share, Size, Trends, Industry Analysis Report, By Component (Equipment, Service); By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The patient-centered strategy used in home healthcare provides numerous benefits, including better patient outcomes, longer care duration, cost-effectiveness, and fewer unnecessary hospitalizations. Because of these benefits, increasing adoption of home health care is expected to drive growth in the home healthcare market.

The global home healthcare market is expanding due to the increasing adoption of telehealth technology in the healthcare system, with the goal of providing high-quality medical services to patients remotely. The extensive use of advanced technology, combined with a significant increase in research and development initiatives in the telehealth sector, is assisting in the market's expansion.

The rising costs of hospital beds and other medical services have led an increasing number of patients to seek out home-based services that are comfortable, dependable, efficient, and affordable. The demand for essential products such as ventilators, nebulizers, continuous positive airway pressure (CPAP) devices, and similar items remains constant.

The market offers significant opportunities due to factors such as increased awareness of home healthcare services in developing regions, quick adoption of advanced technology in home-based healthcare, and a growing geriatric population dealing with health conditions such as Alzheimer's and Dementia. It offers significant opportunities for market players.

A growing number of elderly people prefer to age in their own homes rather than move into assisted living facilities or nursing homes. This trend is primarily driven by the high costs of long-term care, as well as a strong desire to maintain independence and autonomy. Concurrently, nuclear families-those without children in which all adults work-are becoming more common. With limited time available for caregiving, these families frequently turn to professional home healthcare services for the support and assistance required for elderly or disabled family members.

Home Healthcare Market Report Highlights

The service segment held the largest revenue share in the home healthcare market owing to the surging demand for treatments at home. The ageing population is increasing at a great pace, which has enhanced risk of being diagnosed with a chronic disease.

North America accounted for the largest market share. The growing preference of patients for home health care due to benefits such as convenience, cost-effectiveness, privacy, and accessibility of reimbursement for a variety of health services, expansion of services, the launch of numerous products and service providers by medical device manufacturers for use in home health services and settings by home health providers will drive market growth.

Asia-Pacific region witnessed for the fastest growth in the home healthcare market. The region's elderly population is growing rapidly, and this demographic shift, combined with an increase in the prevalence of chronic diseases among the elderly, is driving market growth. Furthermore, rising public awareness about the accessibility and cost-effectiveness of home health services, advancements in healthcare infrastructure, and the introduction of diverse home health solutions by regional entities are expected to have a positive impact on the regional market.

The global key market players include A&D Company, Abbott Laboratories, Amedisys, Almost Family, BAYADA Home Health Care, Bayer AG, Fresenius, GE Healthcare, Kindred Healthcare, Kinnser Software, Linde Corporation, LHC Group, McKesson Corporation, Omron Healthcare, Philips Healthcare, Portea Medical, Roche Holding AG.

Polaris Market Research has segmented the home healthcare market report based on component, and region:

Home Healthcare, Component Outlook (Revenue - USD Billion, 2019 - 2032)

  • Equipment
  • Mobility Assist
  • Therapeutic
  • Diagnostics
  • Service
  • Infusion Therapy Services
  • Telemetry
  • Respiratory Therapy Service
  • Rehabilitation
  • Unskilled Home Care

Home Healthcare, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Home Healthcare Market Insights

  • 4.1. Home Healthcare Market - Industry Snapshot
  • 4.2. Home Healthcare Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Greater availability of home healthcare devices will drive the growth of the market
      • 4.2.1.2. Fast technological advancements in the home healthcare will bolster the growth of the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Deficiency of a health standards as compared to the hospital healthcare will hamper on the growth of the market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Home Healthcare Industry trends
  • 4.7. COVID-19 Impact Analysis

5. Global Home Healthcare Market, by Component

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • 5.3. Equipment
    • 5.3.1. Global Home Healthcare Market, by Equipment, by Region, 2019-2032 (USD Billion)
    • 5.3.2 Mobility Assist
      • 5.3.2.1. Global Home Healthcare Market, by Mobility Assist, by Region, 2019-2032 (USD Billion)
    • 5.3.3. Therapeutic
      • 5.4.3.1. Global Home Healthcare Market, by Therapeutic, by Region, 2019-2032 (USD Billion)
    • 5.3.4. Diagnostics
      • 5.3.4.1. Global Home Healthcare Market, by Diagnostics, by Region, 2019-2032 (USD Billion)
  • 5.4. Service
    • 5.4.1. Global Home Healthcare Market, by Service, by Region, 2019-2032 (USD Billion)
    • 5.4.2. Infusion Therapy Services
      • 5.4.2.1. Global Home Healthcare Market, by Infusion Therapy Services, by Region, 2019-2032 (USD Billion)
    • 5.4.3. Telemetry
      • 5.4.3.1. Global Home Healthcare Market, by Telemetry, by Region, 2019-2032 (USD Billion)
    • 5.4.4. Respiratory Therapy Service
      • 5.4.4.1. Global Home Healthcare Market, by Respiratory Therapy Service, by Region, 2019-2032 (USD Billion)
    • 5.4.5. Rehabilitation
      • 5.4.5.1. Global Home Healthcare Market, by Rehabilitation, by Region, 2019-2032 (USD Billion)
    • 5.4.6. Unskilled Home Care
      • 5.4.6.1. Global Home Healthcare Market, by Merchandise Sales, by Region, 2019-2032 (USD Billion)

6. Global Home Healthcare Market, by Geography

  • 6.1. Key findings
  • 6.2. Introduction
    • 6.2.1. Home Healthcare Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 6.3. Home Healthcare Market - North America
    • 6.3.1. North America: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.3.2. Home Healthcare Market - U.S.
      • 6.3.2.1. U.S.: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.3.3. Home Healthcare Market - Canada
      • 6.3.3.1. Canada: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • 6.4. Home Healthcare Market - Europe
    • 6.4.1. Europe: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.4.2. Home Healthcare Market - UK
      • 6.4.2.1. UK: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.4.3. Home Healthcare Market - France
      • 6.4.3.1. France: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.4.4. Home Healthcare Market - Germany
      • 6.4.4.1. Germany: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.4.5. Home Healthcare Market - Italy
      • 6.4.5.1. Italy: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.4.6. Home Healthcare Market - Spain
      • 6.4.6.1. Spain: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.4.7. Home Healthcare Market - Netherlands
      • 6.4.7.1. Netherlands: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.4.8. Home Healthcare Market - Austria
      • 6.4.8.1. Austria: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • 6.5. Home Healthcare Market - Asia Pacific
    • 6.5.1. Asia Pacific: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.5.2. Home Healthcare Market - China
      • 6.5.2.1. China: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.5.3. Home Healthcare Market - India
      • 6.5.3.1. India: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.5.4. Home Healthcare Market - Malaysia
      • 6.5.4.1. Malaysia: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.5.5. Home Healthcare Market - Japan
      • 6.5.5.1. Japan: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.5.6. Home Healthcare Market - Indonesia
      • 6.5.6.1. Indonesia: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.5.7. Home Healthcare Market - South Korea
      • 6.5.7.1. South Korea: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • 6.6. Home Healthcare Market - Middle East & Africa
    • 6.6.1. Middle East & Africa: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.6.2. Home Healthcare Market - Saudi Arabia
      • 6.6.2.1. Saudi Arabia: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.6.3. Home Healthcare Market - UAE
      • 6.6.3.1. UAE: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.6.4. Home Healthcare Market - Israel
      • 6.6.4.1. Israel: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.6.5. Home Healthcare Market - South Africa
      • 6.6.5.1. South Africa: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
  • 6.7. Home Healthcare Market - Latin America
    • 6.7.1. Latin America: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.7.2. Home Healthcare Market - Mexico
      • 6.7.2.1. Mexico: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.7.3. Home Healthcare Market - Brazil
      • 6.7.3.1. Brazil: Home Healthcare Market, by Component, 2019-2032 (USD Billion)
    • 6.7.4. Home Healthcare Market - Argentina
      • 6.7.4.1. Argentina: Home Healthcare Market, by Component, 2019-2032 (USD Billion)

7. Competitive Landscape

  • 7.1. Expansion and Acquisition Analysis
    • 7.1.1. Expansion
    • 7.1.2. Acquisitions
  • 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

  • 8.1. A&D Company
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Development
  • 8.2. Abbott Laboratories
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Development
  • 8.3. Amedisys
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Development
  • 8.4. Almost Family
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Development
  • 8.5. BAYADA Home Health Care
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Development
  • 8.6. Bayer AG
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Development
  • 8.7. Fresenius
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Development
  • 8.8. GE Healthcare
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Development
  • 8.9. Kindred Healthcare
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Development
  • 8.10. Kinnser Software
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Development
  • 8.11. Linde Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Recent Development
  • 8.12. LHC Group
    • 8.12.1. Company Overview
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Recent Development
  • 8.13. McKesson Corporation
    • 8.13.1. Company Overview
    • 8.13.2. Financial Performance
    • 8.13.3. Product Benchmarking
    • 8.13.4. Recent Development
  • 8.14. Omron Healthcare
    • 8.14.1. Company Overview
    • 8.14.2. Financial Performance
    • 8.14.3. Product Benchmarking
    • 8.14.4. Recent Development
  • 8.15. Philips Healthcare
    • 8.15.1. Company Overview
    • 8.15.2. Financial Performance
    • 8.15.3. Product Benchmarking
    • 8.15.4. Recent Development
  • 8.16. Portea Medical
    • 8.16.1. Company Overview
    • 8.16.2. Financial Performance
    • 8.16.3. Product Benchmarking
    • 8.16.4. Recent Development
  • 8.17. Roche Holding AG
    • 8.17.1. Company Overview
    • 8.17.2. Financial Performance
    • 8.17.3. Product Benchmarking
    • 8.17.4. Recent Development